Maple Grove, MN
Minnesota facilities
We operate two state-of-the-art manufacturing sites in Minnesota. Our Maple Grove facility features 170,000 square feet of finished GMP space, with an additional 100,000 square feet available for future expansion. This site is equipped with serialization and aggregation capabilities and offers comprehensive contract manufacturing services. Our second, smaller facility in Plymouth focuses on packaging activities. Both locations are dedicated to producing high-quality oral solid dosage forms, powders, liquids, and suspensions.
Manufacturing
Our Maple Grove facility is outfitted with state-of-the-art technology, including tablet presses, flud bed granulators, and advanced coating systems, ensuring efficient and precise production. This site also houses robust quality control laboratories and a dedicated R&D team to support product and analytical development as well as innovation. Meanwhile, our Plymouth facility enhances operational flexibility with specialized packaging lines for various dosage forms, seamlessly integrating with the larger Maple Grove operations. Together, these facilities exemplify Bora’s commitment to excellence in pharmaceutical manufacturing.
Compliance
The manufacturing sites in Maple Grove and Plymouth are FDA-approved and meet global health authority requirements. These facilities ensure high-quality production through rigorous quality control, regular audits, and continuous improvement initiatives.
Capabilities
- Oral solid dosage
- Powders
- Liquids
- Suspensions
- R & D
- DEA controlled drugs
- Solvent capable